| # | Drug | Count |
|---|---|---|
| 0 | LEVOTHYROXINE SODIUM | 775 |
| 1 | LEVOTHYROXINE SODIUM ANHYDROUS | 116 |
| 2 | PEMBROLIZUMAB | 74 |
| 3 | ERGOCALCIFEROL | 72 |
| 4 | ROSUVASTATIN | 52 |
| 5 | CALCIUM | 47 |
| 6 | ASPIRIN | 44 |
| 7 | THYROID, PORCINE | 44 |
| 8 | ALEMTUZUMAB | 43 |
| 9 | ASPIRIN 325 MG | 42 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | THYROTROPIN ALFA | 6 | 0.0058 |
| 1 | THYROID, PORCINE | 44 | 0.0041 |
| 2 | LIOTHYRONINE SODIUM | 35 | 0.0040 |
| 3 | CLEMASTINE FUMARATE | 4 | 0.0029 |
| 4 | LEVOTHYROXINE SODIUM | 775 | 0.0025 |
| 5 | ERGOCALCIFEROL | 72 | 0.0024 |
| 6 | ALEMTUZUMAB | 43 | 0.0022 |
| 7 | LEVOTHYROXINE SODIUM ANHYDROUS | 116 | 0.0011 |
| 8 | TEPROTUMUMAB | 6 | 0.0010 |
| 9 | PERINDOPRIL ERBUMINE | 5 | 0.0009 |
| # | Drug class | Count |
|---|---|---|
| 0 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 121 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 87 |
| 2 | HMG-CoA Reductase Inhibitor [EPC] | 75 |
| 3 | Provitamin D2 Compound [EPC] | 72 |
| 4 | Corticosteroid [EPC] | 68 |
| 5 | Benzodiazepine [EPC] | 64 |
| 6 | Vitamin C [EPC] | 48 |
| 7 | Angiotensin 2 Receptor Blocker [EPC] | 47 |
| 8 | Calcium [EPC] | 47 |
| 9 | Kinase Inhibitor [EPC] | 45 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Thyroid Stimulating Hormone [EPC] | 6 | 0.0058 |
| 1 | Interleukin-5 Antagonist [EPC] | 2 | 0.0029 |
| 2 | Provitamin D2 Compound [EPC] | 72 | 0.0024 |
| 3 | CD52-directed Cytolytic Antibody [EPC] | 43 | 0.0022 |
| 4 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 121 | 0.0012 |
| 5 | Insulin-like Growth Factor-1 Receptor Inhibitor [EPC] | 6 | 0.0010 |
| 6 | Progestin Antagonist [EPC] | 3 | 0.0006 |
| 7 | Cannabinoid [EPC] | 4 | 0.0005 |
| 8 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 5 | 0.0005 |
| 9 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 4 | 0.0005 |